)
Andres Isaias
CEO
Restem Group Inc.
Andres Isaias is the chief executive officer of Restem Group, Inc. As the executive leader of Restem, Andres Isaias upholds the company’s vision of bringing safe cell-based therapies to patients lacking access to effective disease treatment options using its platforms, Restem-L its umbilical cord lining progenitor cells (UMPCs) therapy for autoimmune diseases, and activated natural killer cell (aNK) therapeutics targeting senescence and age-
Sessions
-
23-Jun-2026Theater 3Restem Group Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}